183 related articles for article (PubMed ID: 34505148)
21. The p.Thr395Met missense variant of NFIA found in a patient with intellectual disability is a defective variant.
Ogura Y; Uehara T; Ujibe K; Yoshihashi H; Yamada M; Suzuki H; Takenouchi T; Kosaki K; Hirata H
Am J Med Genet A; 2022 Apr; 188(4):1184-1192. PubMed ID: 35018717
[TBL] [Abstract][Full Text] [Related]
22. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
[TBL] [Abstract][Full Text] [Related]
23. Novel variants underlying autosomal recessive neurodevelopmental disorders with intellectual disability in Iranian consanguineous families.
Moudi M; Vahidi Mehrjardi MY; Hozhabri H; Metanat Z; Kalantar SM; Taheri M; Ghasemi N; Dehghani M
J Clin Lab Anal; 2022 Feb; 36(2):e24241. PubMed ID: 35019165
[TBL] [Abstract][Full Text] [Related]
24. BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder.
Scott TM; Guo H; Eichler EE; Rosenfeld JA; Pang K; Liu Z; Lalani S; Bi W; Yang Y; Bacino CA; Streff H; Lewis AM; Koenig MK; Thiffault I; Bellomo A; Everman DB; Jones JR; Stevenson RE; Bernier R; Gilissen C; Pfundt R; Hiatt SM; Cooper GM; Holder JL; Scott DA
Hum Mutat; 2020 May; 41(5):921-925. PubMed ID: 31999386
[TBL] [Abstract][Full Text] [Related]
25. De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
Nabais Sá MJ; El Tekle G; de Brouwer APM; Sawyer SL; Del Gaudio D; Parker MJ; Kanani F; van den Boogaard MH; van Gassen K; Van Allen MI; Wierenga K; Purcarin G; Elias ER; Begtrup A; Keller-Ramey J; Bernasocchi T; van de Wiel L; Gilissen C; Venselaar H; Pfundt R; Vissers LELM; Theurillat JP; de Vries BBA
Am J Hum Genet; 2020 Mar; 106(3):405-411. PubMed ID: 32109420
[TBL] [Abstract][Full Text] [Related]
26. De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated with Mild Dysmorphism.
Zawerton A; Yao B; Yeager JP; Pippucci T; Haseeb A; Smith JD; Wischmann L; Kühl SJ; Dean JCS; Pilz DT; Holder SE; ; ; McNeill A; Graziano C; Lefebvre V
Am J Hum Genet; 2019 Feb; 104(2):246-259. PubMed ID: 30661772
[TBL] [Abstract][Full Text] [Related]
27. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
28. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy.
Parenti I; Lehalle D; Nava C; Torti E; Leitão E; Person R; Mizuguchi T; Matsumoto N; Kato M; Nakamura K; de Man SA; Cope H; Shashi V; ; Friedman J; Joset P; Steindl K; Rauch A; Muffels I; van Hasselt PM; Petit F; Smol T; Le Guyader G; Bilan F; Sorlin A; Vitobello A; Philippe C; van de Laar IMBH; van Slegtenhorst MA; Campeau PM; Au PYB; Nakashima M; Saitsu H; Yamamoto T; Nomura Y; Louie RJ; Lyons MJ; Dobson A; Plomp AS; Motazacker MM; Kaiser FJ; Timberlake AT; Fuchs SA; Depienne C; Mignot C
Hum Genet; 2021 Jul; 140(7):1109-1120. PubMed ID: 33944996
[TBL] [Abstract][Full Text] [Related]
29. De novo variants in ATP2B1 lead to neurodevelopmental delay.
Rahimi MJ; Urban N; Wegler M; Sticht H; Schaefer M; Popp B; Gaunitz F; Morleo M; Nigro V; Maitz S; Mancini GMS; Ruivenkamp C; Suk EK; Bartolomaeus T; Merkenschlager A; Koboldt D; Bartholomew D; Stegmann APA; Sinnema M; Duynisveld I; Salvarinova R; Race S; de Vries BBA; Trimouille A; Naudion S; Marom D; Hamiel U; Henig N; Demurger F; Rahner N; Bartels E; Hamm JA; Putnam AM; Person R; Abou Jamra R; Oppermann H
Am J Hum Genet; 2022 May; 109(5):944-952. PubMed ID: 35358416
[TBL] [Abstract][Full Text] [Related]
30. Severe neurocognitive and growth disorders due to variation in THOC2, an essential component of nuclear mRNA export machinery.
Kumar R; Gardner A; Homan CC; Douglas E; Mefford H; Wieczorek D; Lüdecke HJ; Stark Z; Sadedin S; ; Nowak CB; Douglas J; Parsons G; Mark P; Loidi L; Herman GE; Mihalic Mosher T; Gillespie MK; Brady L; Tarnopolsky M; Madrigal I; Eiris J; Domènech Salgado L; Rabionet R; Strom TM; Ishihara N; Inagaki H; Kurahashi H; Dudding-Byth T; Palmer EE; Field M; Gecz J
Hum Mutat; 2018 Aug; 39(8):1126-1138. PubMed ID: 29851191
[TBL] [Abstract][Full Text] [Related]
31. Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype.
Hiatt SM; Trajkova S; Sebastiano MR; Partridge EC; Abidi FE; Anderson A; Ansar M; Antonarakis SE; Azadi A; Bachmann-Gagescu R; Bartuli A; Benech C; Berkowitz JL; Betti MJ; Brusco A; Cannon A; Caron G; Chen Y; Cochran ME; Coleman TF; Crenshaw MM; Cuisset L; Curry CJ; Darvish H; Demirdas S; Descartes M; Douglas J; Dyment DA; Elloumi HZ; Ermondi G; Faoucher M; Farrow EG; Felker SA; Fisher H; Hurst ACE; Joset P; Kelly MA; Kmoch S; Leadem BR; Lyons MJ; Macchiaiolo M; Magner M; Mandrile G; Mattioli F; McEown M; Meadows SK; Medne L; Meeks NJL; Montgomery S; Napier MP; Natowicz M; Newberry KM; Niceta M; Noskova L; Nowak CB; Noyes AG; Osmond M; Prijoles EJ; Pugh J; Pullano V; Quélin C; Rahimi-Aliabadi S; Rauch A; Redon S; Reymond A; Schwager CR; Sellars EA; Scheuerle AE; Shukarova-Angelovska E; Skraban C; Stolerman E; Sullivan BR; Tartaglia M; Thiffault I; Uguen K; Umaña LA; van Bever Y; van der Crabben SN; van Slegtenhorst MA; Waisfisz Q; Washington C; Rodan LH; Myers RM; Cooper GM
Am J Hum Genet; 2023 Feb; 110(2):215-227. PubMed ID: 36586412
[TBL] [Abstract][Full Text] [Related]
32. Rare and de novo duplications containing TCF20 are associated with a neurodevelopmental disorder.
Lévy J; Cogan G; Maruani A; Maillard A; Dupont C; Drunat S; Rachid M; Atzori P; Delorme R; Jeyarajah S; Isidor B; Pichon O; Moradkhani K; Verloes A; Tabet AC
Clin Genet; 2022 Mar; 101(3):364-370. PubMed ID: 34904221
[TBL] [Abstract][Full Text] [Related]
33. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males.
Kreienkamp HJ; Wagner M; Weigand H; McConkie-Rossell A; McDonald M; Keren B; Mignot C; Gauthier J; Soucy JF; Michaud JL; Dumas M; Smith R; Löbel U; Hempel M; Kubisch C; Denecke J; Campeau PM; Bain JM; Lessel D
Hum Genet; 2022 Feb; 141(2):257-272. PubMed ID: 34907471
[TBL] [Abstract][Full Text] [Related]
34. TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development.
van Woerden GM; Bos M; de Konink C; Distel B; Avagliano Trezza R; Shur NE; Barañano K; Mahida S; Chassevent A; Schreiber A; Erwin AL; Gripp KW; Rehman F; Brulleman S; McCormack R; de Geus G; Kalsner L; Sorlin A; Bruel AL; Koolen DA; Gabriel MK; Rossi M; Fitzpatrick DR; Wilkie AOM; Calpena E; Johnson D; Brooks A; van Slegtenhorst M; Fleischer J; Groepper D; Lindstrom K; Innes AM; Goodwin A; Humberson J; Noyes A; Langley KG; Telegrafi A; Blevins A; Hoffman J; Guillen Sacoto MJ; Juusola J; Monaghan KG; Punj S; Simon M; Pfundt R; Elgersma Y; Kleefstra T
Hum Mutat; 2021 Apr; 42(4):445-459. PubMed ID: 33565190
[TBL] [Abstract][Full Text] [Related]
35. The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype-phenotype correlations, and molecular basis.
Weiss K; Lazar HP; Kurolap A; Martinez AF; Paperna T; Cohen L; Smeland MF; Whalen S; Heide S; Keren B; Terhal P; Irving M; Takaku M; Roberts JD; Petrovich RM; Schrier Vergano SA; Kenney A; Hove H; DeChene E; Quinonez SC; Colin E; Ziegler A; Rumple M; Jain M; Monteil D; Roeder ER; Nugent K; van Haeringen A; Gambello M; Santani A; Medne L; Krock B; Skraban CM; Zackai EH; Dubbs HA; Smol T; Ghoumid J; Parker MJ; Wright M; Turnpenny P; Clayton-Smith J; Metcalfe K; Kurumizaka H; Gelb BD; Baris Feldman H; Campeau PM; Muenke M; Wade PA; Lachlan K
Genet Med; 2020 Feb; 22(2):389-397. PubMed ID: 31388190
[TBL] [Abstract][Full Text] [Related]
36. Clinical and molecular consequences of disease-associated de novo mutations in SATB2.
Bengani H; Handley M; Alvi M; Ibitoye R; Lees M; Lynch SA; Lam W; Fannemel M; Nordgren A; Malmgren H; Kvarnung M; Mehta S; McKee S; Whiteford M; Stewart F; Connell F; Clayton-Smith J; Mansour S; Mohammed S; Fryer A; Morton J; ; Grozeva D; Asam T; Moore D; Sifrim A; McRae J; Hurles ME; Firth HV; Raymond FL; Kini U; Nellåker C; Ddd Study ; FitzPatrick DR
Genet Med; 2017 Aug; 19(8):900-908. PubMed ID: 28151491
[TBL] [Abstract][Full Text] [Related]
37. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
Ju UI; Park JW; Park HS; Kim SJ; Chun YS
Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
[TBL] [Abstract][Full Text] [Related]
38. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
39. The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder.
Rots D; Jakub TE; Keung C; Jackson A; Banka S; Pfundt R; de Vries BBA; van Jaarsveld RH; Hopman SMJ; van Binsbergen E; Valenzuela I; Hempel M; Bierhals T; Kortüm F; Lecoquierre F; Goldenberg A; Hertz JM; Andersen CB; Kibæk M; Prijoles EJ; Stevenson RE; Everman DB; Patterson WG; Meng L; Gijavanekar C; De Dios K; Lakhani S; Levy T; Wagner M; Wieczorek D; Benke PJ; Lopez Garcia MS; Perrier R; Sousa SB; Almeida PM; Simões MJ; Isidor B; Deb W; Schmanski AA; Abdul-Rahman O; Philippe C; Bruel AL; Faivre L; Vitobello A; Thauvin C; Smits JJ; Garavelli L; Caraffi SG; Peluso F; Davis-Keppen L; Platt D; Royer E; Leeuwen L; Sinnema M; Stegmann APA; Stumpel CTRM; Tiller GE; Bosch DGM; Potgieter ST; Joss S; Splitt M; Holden S; Prapa M; Foulds N; Douzgou S; Puura K; Waltes R; Chiocchetti AG; Freitag CM; Satterstrom FK; De Rubeis S; Buxbaum J; Gelb BD; Branko A; Kushima I; Howe J; Scherer SW; Arado A; Baldo C; Patat O; Bénédicte D; Lopergolo D; Santorelli FM; Haack TB; Dufke A; Bertrand M; Falb RJ; Rieß A; Krieg P; Spranger S; Bedeschi MF; Iascone M; Josephi-Taylor S; Roscioli T; Buckley MF; Liebelt J; Dagli AI; Aten E; Hurst ACE; Hicks A; Suri M; Aliu E; Naik S; Sidlow R; Coursimault J; Nicolas G; Küpper H; Petit F; Ibrahim V; Top D; Di Cara F; ; Louie RJ; Stolerman E; Brunner HG; Vissers LELM; Kramer JM; Kleefstra T
Am J Hum Genet; 2023 Jun; 110(6):963-978. PubMed ID: 37196654
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the Role of MAST1 as an Intellectual Disability Disease Gene: Identification of a Novel De Novo Variant in a Patient with Developmental Disabilities.
Ben-Mahmoud A; Al-Shamsi AM; Ali BR; Al-Gazali L
J Mol Neurosci; 2020 Mar; 70(3):320-327. PubMed ID: 31721002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
